Vir Ceo: Omicron Is Probably Not The Last Variant

Vir Biotechnology President and CEO George Scangos joins Emily Chang following the news that its Covid-19 antibody treatment, co-developed with Glaxo, looks to be effective against the new omicron variant in early testing.

#bloomberg